What does Dr. M. Sente, huisarts do?

Dr. M. Sente, huisarts is a general practice in Holsbeek. Private Limited, started on 6 November 2006, 1 establishment.

What is the address of Dr. M. Sente, huisarts?

The registered office of Dr. M. Sente, huisarts is located at Gobbelsrode 61, 3220 Holsbeek.

Is Dr. M. Sente, huisarts still active?

Yes. According to the CBE (29 September 2026) Dr. M. Sente, huisarts is active, legal situation “Normale toestand”, started on 6 November 2006.

Is Dr. M. Sente, huisarts registered on Peppol?

Yes, Dr. M. Sente, huisarts is registered on the Peppol network with ID 0208:0885033641.

What is the enterprise number of Dr. M. Sente, huisarts?

The enterprise number of Dr. M. Sente, huisarts is BE0885033641.

When was Dr. M. Sente, huisarts founded?

Dr. M. Sente, huisarts was founded on 6 November 2006.

Who are the directors of Dr. M. Sente, huisarts?

According to the 2025 annual accounts, the directors of Dr. M. Sente, huisarts are: Marina Sente.

Is Dr. M. Sente, huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. M. Sente, huisarts make in 2025?

Dr. M. Sente, huisarts posted a profit after taxes of € 12,171 in financial year 2025.

What is the revenue of Dr. M. Sente, huisarts?

As a small company, Dr. M. Sente, huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 34,147.

Dr. M. Sente, huisarts (Private Limited) - Holsbeek

Dossier Dr. M. Sente, huisarts, printed on 29 September 2026 from databakkes.be/en/0885033641/dr-m-sente-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. M. Sente, huisarts from Holsbeek, company number BE0885033641, closed financial year 2025 with a result of € 12,171 after tax. For that financial year Dr. M. Sente, huisarts recorded a gross margin of € 34,147 and equity of € 164,907. Compared with financial year 2024, the result moved from € 13,329 to € 12,171. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 164,907

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12,171

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,349

▲ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 152,507.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 5,881

▼ 57% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 35,464

▼ 18% vs 2024

€ 6,140 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 1,489

▲ 98% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 11,446 Gross margin 2022: € 11,446 First fiscal year in the series	€ 34,611 Gross margin 2023: € 34,611 ▲ 202% vs 2022 (€ 11,446) Favourable step	€ 42,982 Gross margin 2024: € 42,982 ▲ 24% vs 2023 (€ 34,611) Favourable step	€ 34,147 Gross margin 2025: € 34,147 ▼ 21% vs 2024 (€ 42,982) Unfavourable step	▼ 21%
Profit after taxes	€ -8,151 Profit after taxes 2022: € -8,151 First fiscal year in the series	€ 9,055 Profit after taxes 2023: € 9,055 ▲ € 17,206 vs 2022 (€ -8,151) Favourable step	€ 13,329 Profit after taxes 2024: € 13,329 ▲ 47% vs 2023 (€ 9,055) Favourable step	€ 12,171 Profit after taxes 2025: € 12,171 ▼ 9% vs 2024 (€ 13,329) Unfavourable step	▼ 9%
Equity	€ 154,351 Equity 2022: € 154,351 First fiscal year in the series	€ 139,406 Equity 2023: € 139,406 ▼ 10% vs 2022 (€ 154,351) Unfavourable step	€ 152,735 Equity 2024: € 152,735 ▲ 10% vs 2023 (€ 139,406) Favourable step	€ 164,907 Equity 2025: € 164,907 ▲ 8% vs 2024 (€ 152,735) Favourable step	▲ 8%
Total debts	€ 134,529 Total debts 2022: € 134,529 First fiscal year in the series	€ 139,258 Total debts 2023: € 139,258 ▲ 4% vs 2022 (€ 134,529) Unfavourable step	€ 109,325 Total debts 2024: € 109,325 ▼ 21% vs 2023 (€ 139,258) Favourable step	€ 91,503 Total debts 2025: € 91,503 ▼ 16% vs 2024 (€ 109,325) Favourable step	▼ 16%
Cash	€ 47,310 Cash 2022: € 47,310 First fiscal year in the series	€ 46,422 Cash 2023: € 46,422 ▼ 2% vs 2022 (€ 47,310) Unfavourable step	€ 54,601 Cash 2024: € 54,601 ▲ 18% vs 2023 (€ 46,422) Favourable step	€ 70,349 Cash 2025: € 70,349 ▲ 29% vs 2024 (€ 54,601) Favourable step	▲ 29%
Land & buildings	€ 121,360 Land & buildings 2022: € 121,360 First fiscal year in the series	€ 115,440 Land & buildings 2023: € 115,440 ▼ 5% vs 2022 (€ 121,360) Unchanged	€ 109,520 Land & buildings 2024: € 109,520 ▼ 5% vs 2023 (€ 115,440) Unchanged	€ 111,645 Land & buildings 2025: € 111,645 ▲ 2% vs 2024 (€ 109,520) Unchanged	▲ 2%
Retained profit	€ 141,951 Retained profit 2022: € 141,951 First fiscal year in the series	€ 127,006 Retained profit 2023: € 127,006 ▼ 11% vs 2022 (€ 141,951) Unfavourable step	€ 140,335 Retained profit 2024: € 140,335 ▲ 10% vs 2023 (€ 127,006) Favourable step	€ 152,507 Retained profit 2025: € 152,507 ▲ 9% vs 2024 (€ 140,335) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 24,000 Dividend 2023: € 24,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 24,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 65,353 Bank debt 2022: € 65,353 First fiscal year in the series	€ 54,352 Bank debt 2023: € 54,352 ▼ 17% vs 2022 (€ 65,353) Favourable step	€ 43,252 Bank debt 2024: € 43,252 ▼ 20% vs 2023 (€ 54,352) Favourable step	€ 35,464 Bank debt 2025: € 35,464 ▼ 18% vs 2024 (€ 43,252) Favourable step	▼ 18%
Balance sheet total	€ 288,880 Balance sheet total 2022: € 288,880 First fiscal year in the series	€ 278,665 Balance sheet total 2023: € 278,665 ▼ 4% vs 2022 (€ 288,880) Unchanged	€ 262,061 Balance sheet total 2024: € 262,061 ▼ 6% vs 2023 (€ 278,665) Unchanged	€ 256,410 Balance sheet total 2025: € 256,410 ▼ 2% vs 2024 (€ 262,061) Unchanged	▼ 2%

Key figures of Dr. M. Sente, huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. M. Sente, huisarts?

What happened at Dr. M. Sente, huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 12,171 (▼ 9% vs 2024). filed late Source: NBB ↗
Jul 19, 2007 New establishment in Holsbeek. KBO
Nov 6, 2006 Start of the company according to the CBE. KBO

In short

From € 8,151 loss in 2022 to € 12,171 profit in 2025.

Paid € 16,364 in corporate taxes since 2022.

Best year ever: 2024, with € 13,329 profit.

Paid out € 24,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. M. Sente, huisarts? We notify you, reason included.

Follow Dr. M. Sente, huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marina Sente

Dr. M. Sente, huisarts

Behind Dr. M. Sente, huisarts is Marina Sente.

See the full network in the app

Directors

According to the 2025 annual accounts

Marina Sente

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gobbelsrode 61

3220 Holsbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0885.033.641
VAT number: BE 0885.033.641
Registered office: Gobbelsrode 61, 3220 Holsbeek
Names & denominations: Dr. M. Sente, huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2006
Peppol: Active · Active since 17 Oct 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗